1388 related articles for article (PubMed ID: 18773381)
21. Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial.
Van De Water M; Kessel ET; De Kleine MJ; Oei SG
Acta Obstet Gynecol Scand; 2008; 87(3):340-5. PubMed ID: 18307075
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of preterm delivery with calcium channel blockers--Nifedipine].
Nikolov A; Markov D; Dimitrov A; Ivanov S; Diavolov V
Akush Ginekol (Sofiia); 2007; 46(9):18-22. PubMed ID: 18642559
[TBL] [Abstract][Full Text] [Related]
23. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
Wenstrom KD; Weiner CP; Merrill D; Niebyl J
Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
[TBL] [Abstract][Full Text] [Related]
24. Nifedipine versus ritodrine for suppression of preterm labor. Comparison of their efficacy and secondary effects.
Cararach V; Palacio M; Martínez S; Deulofeu P; Sánchez M; Cobo T; Coll O
Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):204-8. PubMed ID: 16310305
[TBL] [Abstract][Full Text] [Related]
25. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study.
How HY; Zafaranchi L; Stella CL; Recht K; Maxwell RA; Sibai BM; Spinnato JA
Am J Obstet Gynecol; 2006 Apr; 194(4):976-81. PubMed ID: 16580286
[TBL] [Abstract][Full Text] [Related]
26. Tocolytic treatment for preterm contractions with and without cervical changes.
Brown HL; Hiett AK; Britton KA; Turnquest MA; Golichowski AM
Am J Perinatol; 1997 Aug; 14(7):405-9. PubMed ID: 9263560
[TBL] [Abstract][Full Text] [Related]
27. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations.
Lam F; Bergauer NK; Jacques D; Coleman SK; Stanziano GJ
J Perinatol; 2001; 21(7):444-50. PubMed ID: 11894512
[TBL] [Abstract][Full Text] [Related]
28. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
[TBL] [Abstract][Full Text] [Related]
29. The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth prevention.
Joy S; Rhea DJ; Istwan NB; Desch CN; Stanziano G
Am J Perinatol; 2010 Apr; 27(4):343-8. PubMed ID: 20013580
[TBL] [Abstract][Full Text] [Related]
30. Two dose regimens of nifedipine for management of preterm labor: a randomized controlled trial.
Nassar AH; Abu-Musa AA; Awwad J; Khalil A; Tabbara J; Usta IM
Am J Perinatol; 2009 Sep; 26(8):575-81. PubMed ID: 19399705
[TBL] [Abstract][Full Text] [Related]
31. Oral terbutaline after parenteral tocolysis.
Lagace E
J Fam Pract; 1997 Feb; 44(2):131-2. PubMed ID: 9040511
[No Abstract] [Full Text] [Related]
32. Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth.
Allbert JR; Wise CA; Lou CH; Gookin KS; Parmenter MA; Morrison JC
J Perinatol; 1992 Mar; 12(1):28-31. PubMed ID: 1348530
[TBL] [Abstract][Full Text] [Related]
33. Tocolytic therapy for acute preterm labor.
Abramovici A; Cantu J; Jenkins SM
Obstet Gynecol Clin North Am; 2012 Mar; 39(1):77-87. PubMed ID: 22370109
[TBL] [Abstract][Full Text] [Related]
34. [Indications for respiratory complications during the use of oral nifedipine as a tocolytic agent, especially in patients with multiple pregnancies].
Oei SG; Van de Water M
Ned Tijdschr Geneeskd; 2007 May; 151(19):1100; author reply 1100-1. PubMed ID: 17552423
[No Abstract] [Full Text] [Related]
35. Clinical comparison of oral nifedipine and subcutaneous terbutaline for initial tocolysis.
Smith CS; Woodland MB
Am J Perinatol; 1993 Jul; 10(4):280-4. PubMed ID: 8397562
[TBL] [Abstract][Full Text] [Related]
36. A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations.
Lam F; Bergauer NK; Coleman SK; Stanziano GJ; Jacques D
J Perinatol; 2000; 20(7):408-13. PubMed ID: 11076323
[TBL] [Abstract][Full Text] [Related]
37. The impact of hydramnios on pregnancy outcome in twin gestations.
Orhan A; Kurzel RB; Istwan NB; Rhea D; Burgess E; Stanziano G
J Perinatol; 2005 Jan; 25(1):8-10. PubMed ID: 15496872
[TBL] [Abstract][Full Text] [Related]
38. [Indications for respiratory complications during the use of oral nifedipine as a tocolytic agent, especially in patients with multiple pregnancies].
Lenglet JE; van Geijn HP; van Schijndel RJ; Vonk Noordegraaf A; Bolte AC
Ned Tijdschr Geneeskd; 2007 Jan; 151(3):198-205. PubMed ID: 17288347
[TBL] [Abstract][Full Text] [Related]
39. Atosiban and nifedipine in acute tocolysis: a comparative study.
Al-Omari WR; Al-Shammaa HB; Al-Tikriti EM; Ahmed KW
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):129-34. PubMed ID: 16446025
[TBL] [Abstract][Full Text] [Related]
40. Association of tocolytic therapy with antenatal steroid administration and infant outcomes. Newborn Lung Project.
Palta M; Sadek M; Lim TS; Evans M; McGuinness G
Am J Perinatol; 1998 Feb; 15(2):87-92. PubMed ID: 9514131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
